Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
This study is ongoing, but not recruiting participants.
Study NCT00314743
Information provided by Washington University School of Medicine
First Received: April 12, 2006
Last Updated: April 15, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
